Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Mem. Inst. Oswaldo Cruz ; 103(8): 809-812, Dec. 2008. tab
Article Dans Anglais | LILACS | ID: lil-502301

Résumé

This study was performed with the purpose of testing the hypothesis that the high prevalence of hepatitis C among former athletes is associated with their past use of injectable stimulants. The study involved the participation of 208 former professional and amateur soccer and basketball players from the region of Ribeirão Preto, Brazil, who answered a questionnaire regarding their exposure to risk factors, including the use of injectable stimulants in the time they were engaged in sporting activities. ELISA tests were used to detect infection by the hepatitis C virus, and confirmed with PCR and genotyping for the positive cases. It was observed that the former use of injectable stimulants was a practice disseminated among the participants (24.5 percent), reaching 50.8 percent in the professionals. The overall prevalence for hepatitis C was 7.2 percent, with values of 11 percent among professionals and 5.5 percent among amateurs. In both categories, the presence of infection was markedly higher among those who admitted past use of injectable stimulants when compared to those who denied such practice (36 percent and 0.8 percent among amateurs; 21.9 percent and 0 percent among professionals, respectively). Multivariate analysis showed that the use of those substances was the only variable associated with the risk of hepatitis C. This confirms previous observations, performed with reduced sample sizes and without comparison groups, which indicated that the use of injectable vitamins was a risk factor of hepatitis C among former athletes.


Sujets)
Adulte , Sujet âgé , Humains , Mâle , Adulte d'âge moyen , Basketball/statistiques et données numériques , Stimulants du système nerveux central/administration et posologie , Hépatite C/transmission , Football/statistiques et données numériques , Brésil/épidémiologie , Test ELISA , Hepacivirus/génétique , Hepacivirus/immunologie , Anticorps de l'hépatite C/sang , Hépatite C/diagnostic , Hépatite C/épidémiologie , Injections veineuses/effets indésirables , Réaction de polymérisation en chaîne , Prévalence , Facteurs de risque
SÉLECTION CITATIONS
Détails de la recherche